ANTARES PHARMA, INC.·4

Aug 7, 6:14 PM ET

Tursi James Patrick 4

4 · ANTARES PHARMA, INC. · Filed Aug 7, 2018

Insider Transaction Report

Form 4
Period: 2018-08-06
Tursi James Patrick
EVP, Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-08-06+150,000150,000 total
    Exercise: $2.89Exp: 2028-08-06Common Stock (150,000 underlying)
Footnotes (2)
  • [F1]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
  • [F2]The options vest in equal quarterly installments over three years from the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION